Delayed Injection Site Reaction to Fremanezumab for Chronic Migraine Treatment.
Year: 2023
Type: article
Study design: Case Report
Source: PubMed
Authors: Kevin V Thomas, Daniel D Bennett, Justin Endo
Institution: University of Wisconsin–Madison
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4372334367